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1. Introduction
As one of the major health problems in the world, diabetes affects over 346 million people
worldwide. In United States alone, according to the statistical fact sheet released 2011 by
American Diabetes Association, 25.8 million children and adults accounting for 8.3% of the
population are affected by diabetes. Unfortunately, the therapy of diabetes remains unsatis‐
fied despite of extensive studies in the last decades. Diabetes can be categorized into two
main types: type 1 and type 2. Type 1 diabetes mellitus, used to known as juvenile diabetes,
is typically developed in children and juveniles. Despite the increasing rate of Type 2 diabe‐
tes in the United States, type 1 diabetes accounts for over 2/3 of new adolescent diabetes di‐
agnoses. Although most commonly presented in childhood, type 1 diabetes also accounts
for 5-10% cases of adult diabetes (1). Recent epidemiologic studies revealed that the inci‐
dence for type 1 diabetes in most regions of the world has increased by 2-5% (2).
Unlike type 2 diabetes, which is caused by the loss of insulin sensitivity, type 1 diabetes
is  caused  by  insulin  deficiency  following  destruction  of  insulin-producing  pancreatic  β
cells.  Autoimmune-mediated β  cell  death has  been considered as  the  major  cause  of  β-
cell  loss  in  type  1  diabetes.  However,  the  underlying  mechanisms  are  not  fully  under‐
stood.  Accumulating  evidence  suggests  an  involvement  of  endoplasmic  reticulum  (ER)
stress in multiple biological processes during the development of type 1 diabetes. Pancre‐
atic β cells exhibit exquisite sensitivity to ER stress due to their high development in or‐
der to secrete large amounts of insulin. There is also evidence supporting that ER stress
regulates the immune cell functionality and cytokine production that is relevant to auto‐
immune processes in type 1 diabetes. Furthermore, β cell loss caused by autoimmune at‐
tack results in an increased ER burden on the rest pancreatic β cells and induces unfolded
protein response (UPR) and ER stress, which further exacerbates β cell death. Here I will
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summarize the functional involvement of ER stress in the pathogenesis of type 1 diabetes
and the potential underlying mechanisms.
2. Pancreatic β cell and blood glucose regulation
2.1. Blood glucose regulation by pancreas
The major cause of type 1 diabetes is loss of insulin-secreting pancreatic β cell and insu‐
lin  inadequacy (3;4).  For  a  better  understanding of  the  pathogenesis  of  type 1  diabetes,
the  regulatory  mechanisms  of  blood  glucose  by  pancreaswill  briefly  introduced.  Blood
glucose level is closely regulated in order to provide a homeostatic microenvironment for
tissues  and  organs.  According  to  the  American  Diabetes  Association,  a  normal  fasting
blood glucose level is between 70 to 100 mg/dL, and the recommended fasting level is to
aim for 70 to 130 mg/dL and less than 180 mg/dL after meals (5). Blood glucose is moni‐
tored by the cells in the islets of Langerhans (6). Islets of Langerhans are clusters of pan‐
creatic cells that execute the endocrine function of pancreas. They contain the following 4
types of cells, in order of abundance: β cells, α cells, δ cells, and γ cells. Pancreatic β cells
and α cells make up about 70% and 17% of islet cells respectively, and both of them are
responsible for the blood glucose regulation by producing insulin (β cells) and glucagon
(α cells) (6).  Pancreatic δ cells produce somatostatin which has a major inhibitory effect,
including on pancreatic juice production. Pancreatic γ cells secrete pancreatic polypeptide
that is responsible for reducing appetite.
Insulin and glucagon have opposite functions on glucose regulation. They keep blood glu‐
cose level in a normal range by coordinating with each other (Figure 1). After a meal, the
digestive system breaks down the carbohydrates to small sugar molecules, mainly glucose.
The glucose is then absorbed across the intestinal wall and travel to the circulating blood‐
stream. Pancreatic β cells sense increased blood glucose level by taking up glucose through
GLUT2, a glucose transporter. The metabolism of glucose in β cells leads to the increase of
ATP/ADP ratio, which causes the closing of ATP-sensitive potassium channels and further
leads to the open of calcium channels on membrane. The resulting increase of intracellular
calcium concentration promotes the secretion of insulin into circulation of blood. Circulating
insulin then acts on cells in a variety of tissues including liver, muscle, and fat through inter‐
acting with insulin receptor on the cell membrane. Insulin signaling induces the transloca‐
tion of glucose transporter GLUT4 to cell membrane of muscle cells and adipocytes, leading
to the uptake of glucose into cells as an energy source. In addition, insulin signaling also
stimulates the conversion of glucose into glycogen, a process called glycogenesis, in liver.
Therefore, insulin lowers blood glucose level by promoting glycogenesis and glucose uptake
by peripheral tissues (7). In contrast, a drop in blood glucose caused by starving or other sit‐
uations like extreme exercise suppresses the secretion of insulin by β cells and stimulates α
cells of pancreas to release glucagon. Glucagon acts on liver and promotes glucose produc‐
tion by the breakdown of glycogen to glucose (called glycogenolysis), resulting in the in‐
crease of blood glucose.
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Figure 1. Homeostatic regulation of blood glucose by pancreas. Pancreas is the major organ responsible for main‐
taining the blood glucose homeostasis. Increase of blood glucose level can be sensed by GLUT2 on β cells, a glucose
transporter. The metabolism of glucose in β cells promotes the secretion of insulin into circulation of blood. Circulat‐
ing insulin then increases the glucose uptake by a variety of tissues including liver, muscle, and fat. In liver, insulin sig‐
naling also stimulates the conversion of glucose into glycogen, a process called glycogenesis. Both glycogenesis and
glucose uptake by peripheral tissues can lead to a decrease of glucose level in blood stream. In contrast, a drop of
blood glucose level suppresses the secretion of insulin by β cells and stimulates α cells to release glucagon. Glucagon
acts on liver and promotes glucose production by the breakdown of glycogen to glucose, a process called glycogenol‐
ysis, and results in the increase of blood glucose.
2.2. Pancreatic β cells and insulin biosynthesis
Either insulin deficiency or insulin inefficiency can cause diabetes. As the only cell type pro‐
ducing insulin, β cell plays a critical role in the development of diabetes. In type 1 diabetes,
autoimmune-mediated destruction of β cell leads to insufficient insulin production and in‐
ability of cells to take up glucose. In contrast, type 2 diabetes is caused by loss of insulin sen‐
sitivity. In response to insulin resistance, the body secretes more insulin to overcome the
impaired insulin action. However, pancreatic β cells fail to secrete sufficient insulin to over‐
come insulin resistance in some individuals, resulting in type 2 diabetes (8;9). Therefore,
dysfunction of β cell exists in both types of diabetes.
Pancreatic β cell is specialized for production of insulin to control blood glucose level. In re‐
sponse to hyperglycemia, insulin is secreted from a readily available pool in β cells. In the
meantime, the secretion of insulin activates the biosynthesis of insulin (10). Insulin is first
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synthesized as preproinsulin with a signal peptide in the ribosomes of the rough endoplas‐
mic reticulum. Preproinsulin is translocated into ER lumen by interaction of signal peptide
with signal recognition particle on the ER membrane. Preproinsulin is converted to proinsu‐
lin by removing the signal peptide forming three disulfide bonds in the ER. Proinsulin is
then translocated into Golgi apparatus and packaged into secretory granules that are close
to the cell membrane. In the secretory granules, proinsulin is cleaved into equal amounts of
insulin and C-peptide (Figure 2). Insulin is accumulated and stored in the secretory gran‐
ules. When the β cell is appropriately stimulated, insulin is secreted from the cell by exocy‐
tosis (11). As the major site for protein synthesis, ER plays an important role in insulin
biosynthesis. To fulfill the requirement for secreting large amount of insulin, the pancreatic
β cells are equipped with highly developed ER, leading to the vulnerability of β cell to ER
stress (12). In type 1 diabetes, the loss of β cell increases the burden of insulin secretion on
the residual β cells. On the on hand, this compensated action is beneficial for the control of
blood glucose. On the other hand, it also increases the ER burden of residual β cells, which
further exacerbates β cell death.
Figure 2. Biosynthesis of insulin in β cell. In the ribosomes of rough endoplasmic reticulum, insulin is first synthe‐
sized as a precursor, preproinsulin. Preproinsulin has a signal peptide that directs it to translocate into ER lumen by
interacting with signal recognition particle on the ER membrane. In ER lumen, preproinsulin is converted to proinsulin
by removing the signal peptide and forming three disulfide bonds. Proinsulin is then translocated into Golgi apparatus
and packaged into secretory granules where it is cleaved into equal amounts of insulin and C-peptide. After synthesis,
insulin is stored in the secretory granules and secreted from the cell until the β cell is appropriately stimulated.
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3. Biological characterization of endoplasmic reticulum (ER) and ER
stress
3.1. Endoplasmic reticulum
Endoplasmic Reticulum (ER) is an organelle of eukaryotic cells that is responsible for the fa‐
cilitation of protein folding and assembly (13-15), manufacture of the membranes(16), bio‐
synthesis of lipid and sterol, storage of intracellular Ca2+, and transport of synthesized
proteins in cisternae.It is a membranous network of tubules, vesicles, and cisternae that are
interconnected by the cytoskeleton.The ER is well developed in endocrine cells such as β cell
in which large amounts of secretory proteins are synthesized.
ER is categorized into two types: rough endoplasmic reticulum (RER) and smooth endoplas‐
mic reticulum (SER). As featured by its name, RER looks bumpy and rough under a micro‐
scope due to the ribosomes on the outer surfaces of the cisternae. RER is in charge for
protein synthesis. The newly synthesized proteins are folded into 3-dimensional structure in
RER and sent to Golgi complex or membrane via small vesicles. In contrast, SER appears to
have a smooth surface under the microscope as it does not have ribosomes on its cisternae.
SER is responsible for the synthesis of lipids and steroids, regulation of calcium concentra‐
tion, attachment of receptors on cell membrane proteins, and detoxification of drugs. It is
found commonly in places such as in the liver and muscle. It is important for the liver to
detoxify poisonous substances. Sarcoplasmic reticulum is a special type of SER. It is found
in smooth and striated muscle, and is important for the regulation of calcium levels. It se‐
questers a large store of calcium and releases them when the muscle cell is stimulated.
3.2. Unfolded protein response and ER stress
ER stress is defined as the cellular responses to the disturbances of normal function of ER.
The most common cause of ER stress is protein mis-folding. ER is the place where newly
produced proteins fold into 3-dimensional conformation which is essential for their biologi‐
cal function. The sensitive folding environment could be disturbed by a variety of pathologi‐
cal insults like environmental toxins, viral infection, and inflammation. In addition to
pathological insults, it can also be induce by many physiological processes such as overload‐
ed protein biosynthesis on ER, For example, in case of type 1 diabetes, increased insulin syn‐
thesis in residual β cell exceeds the folding capacity of ER, resulting in the accumulation of
unfolded insulin. The accumulation of unfolded or mis-folded proteins in the ER leads a
protective pathway to restore ER function, termed as unfolded protein response (UPR).
Protein folding requires a serial of ER-resident protein folding machinery. A special type of
proteins called chaperones is used as a quality control mechanism in the ER. As the major
mechanisms to promote protein folding, chaperones assist protein folding by interacting
with the newly synthesized proteins.In addition,chaperones also help to break down un‐
folded or incorrectly folded proteins in the ER via a process called ER associated degrada‐
tion.The monitoring mechanism ensures the correct protein folding in the ER. The unfolded
proteins usually have a higher number of hydrophobic surface patches than that of proteins
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with native conformation (17). Thus, unfolded proteins are prone to aggregate with each
other in a crowed environment and directed to degradative pathway (18). Molecular chaper‐
ones in the ER preferentially interact with hydrophobic surface patches on unfolded pro‐
teins and create a private folding environment by preventing unfolded proteins from
interaction and aggregation with other unfolded proteins. In addition, the concentration of
Ca2+ in ER also impairs protein folding by inhibiting the activity of ER-resident chaperones
and foldases (19-22). ER is the major site for Ca2+ storage in mammalian cells. The concentra‐
tion of Ca2+ in ER is thousands times higher than that in the cytosol (23). Most chaperones
and foldases in ER are vigorous Ca2+ binding proteins. Their activity, therefore, is affected by
the concentration of Ca2+ in ER.
Exhaustion of the protein folding machineries or insufficient energy supply increases the ac‐
cumulation of unfolded or mis-folded proteins in ER, which is responsible for the activation
of UPR. UPR is a protective mechanism by which it monitors and maintains the homeostasis
of ER. Various physiological and pathological insults such as increased protein synthesis,
failure of posttranslational modifications, nutrient/glucose starvation, hypoxia, and altera‐
tions in calcium homeostasis, can result in the accumulation of unfolded or mis-folded pro‐
teins in ER which further causes ER stress (24).For example, altered expression of
antithrombin III (25;26) or blood coagulation factor VIII (27;28), may result in the exhaustion
of protein folding machinery and thus induces UPR. Some physiological processes such as
the differentiation of B lymphocytes into plasma cells along with the development of highly
specialized secretory capacity can also cause unfolded protein accumulation and activate
UPR (29-31). In response to those physiological and pathological insults, cells initiate UPR
process to get rid of the unfolded or mis-folded proteins. For instance, UPR can increase the
folding capacity by up-regulating ER chaperones and foldases, as well as attenuate the bio‐
synthetic burden through down-regulating the expression of secreted proteins (32-34). In
addition, UPR also eliminates unfolded or mis-folded proteins by activating ER associated
degradation process (35-37). However, once the stress is beyond the compensatory capacity
of UPR, the cells would undergo apoptosis. As such, UPR and ER stress are reported to be
implicated in a variety of pathological processes, including diabetes, neurodegenerative dis‐
eases, pathogenic infections, atherosclerosis, and ischemia (24;38).
In addition to protein folding, a variety of post-translational modifications including N-
linked glycosylation, disulfide bond formation, lipidation, hydroxylation, and oligomeriza‐
tion, occur in ER. Disruption of those post-translational modifications can also result in the
accumulation of incorrectly folded proteins and thereby induce UPR or ER stress. For exam‐
ple, glucose deprivation impairs the process for N-linked protein glycosylation and thus
leads to ER stress (39).
3.3. ER stress pathways
As a protective mechanism during ER stress, UPR initiates a variety of process to ensure the
homeostasis of ER. UPR can be mediated by three major pathways, which are initiated by
the three transmembrane signaling proteins located on the ER membrane. Those transmem‐
brane proteins function as a bridge linking cytosol and ER with their C-terminal in the cyto‐
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sol and N-terminal in the ER lumen. The N-terminal is usually engaged by an ER resident
chaperone BiP (Grp78) to avoid aggregation. When unfolded proteins accumulate in ER,
chaperons are occupied by unfolded proteins and release those transmembrane signaling
proteins. There are three axes of signals that are initiated by the pancreatic endoplasmic re‐
ticulum kinase (PERK), the inositol-requiring enzyme 1 (IRE1), and the activating transcrip‐
tion factor 6 (ATF6) respectively. The release of these proteins from BiP triggers UPR and ER
stress (Figure 3).
Figure 3. UPR signal pathways. Under normal condition, PERK, IRE1, and ATF6 binding to the ER chaperone BiP to
remain inactive state. Upon the accumulation of unfolded proteins, BiP preferentially binds to the unfolded proteins,
leading to the release of PERK, IRE1, and ATF6. PERK becomes oligomerized and activated once released from BiP, and
subsequently phosphorylates eIF2α. The phosphorylation of eIF2α results in the suppression of the overall transcrip‐
tion of mRNAs and selectively enhanced transcription of genes implicated in UPR such as the ATF4 mRNA. Similar to
PERK, IRE1 is dimerized and activated after released from BiP. Activated IRE1 induces XBP-1 by enhancing the splicing
of its mRNA. XBP-1 enhances UPR by regulating the transcription of its target genes. The detachment of ATF6 from BiP
results in the translocation of ATF6 to the Golgi apparatus and cleavage of ATF6. Cleaved ATF6 then translocates into
the nucleus and initiates the transcription of target genes.
PERK/eIF2α/ATF4 axis: PERK is a type I transmembrane Ser/Thr protein kinase uniquely
present in ER. In response to ER stress, the binding of unfolded proteins to BiP leads to the
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release of PERK from BiP. Once released from BiP, PERK becomes oligomerized and auto‐
phosphorylated. As a result, PERK inactivates eukaryotic initiation factor 2α (eIF2α) by the
phosphorylation of Ser51 to inhibit mRNA translation and protein load on ER (34;40). In ad‐
dition, phosphorylated eIF2α also promotes the expression of stress-induced genes includ‐
ing the transcription factors ATF4 and CCAAT/enhancer binding protein (C/EBP)
homologous protein (CHOP) (41). Deficiency of PERK results in an abnormally elevated
protein synthesis in response to the accumulation of unfolded proteins in ER.
IRE1/XBP-1 axis: IRE1 is another axis of signal involved in UPR. There are 2 isoforms of
IRE1: IRE1α and IRE1β. IRE1α is expressed in most cells and tissues, while IRE1β is restrict‐
ed in intestinal epithelial cells (42;43). Once disassociated with BiP, IRE1 becomes activated.
Activated IRE1 possesses endoribonuclease activity and cleaves 26 nucleotides from the
mRNA encoding X-box binding protein-1 (XBP-1), resulting in the increased production of
XBP-1 (44). XBP-1 is a transcriptional factor belonging to basic leucine zipper transcription
factorfamily. It heterodimerizes with NF-Y and enhances gene transcription by binding to
the ER stress enhancer and unfolded protein response element in the promoters of targeted
genes involved in ER expansion, protein maturation, folding and export from the ER, and
degradation of mis-folded proteins (44-49). In addition, IRE1α also mediates the degradation
of ER-targeted mRNAs, thus decreasing the ER burden (50).
ATF6 axis: The third axis of ER stress signal is mediated by ATF6. Unlike PERK and IRE1
which oligomerize upon UPR, ATF6 translocates into the Golgi apparatus after released
from BiP. The transmembrane domain is then cleaved in the Golgi apparatus (51). The 50-
kDa cleaved ATF6 is relocated into the nucleus where it binds to the ER stress response ele‐
ment CCAAT(N)9CCACG to regulate the expression of targeted genes. For example, once
released from the ER membrane, ATF6 enhances the transcription of XBP-1 mRNA which is
further regulated by IRE1 (44). In addition, ATF6 also increases the expression of the two
major chaperon systems in the ER: calnexin/calreticulin and BiP/GRP94 (44;52;53).
4. The implication of ER stress in autoimmune responses
4.1. ER stress and innate immune response
The importance of innate immunity was highlighted in the pathophysiology of type 1 diabe‐
tes (54-57). Type 1 diabetes was initially considered a T-cell-mediated autoimmune disease
(58), in which T-cell was believed as the major immune cell causing β cell destruction while
the involvement of innate immune response has been ignored for a long time. However, re‐
cent studies suggest a critical role of innate immune responses in the development of type 1
diabetes (54;55). As the first line of defense mechanism, innate immunity is implicated in the
initiation as well as the progression of autoimmune responses against pancreatic β cell.
Innate immune response is regulated by elements of the UPR pathway (59). For example,
Cyclic-AMP-responsive-element-binding protein H(CREBH), an ER stress-associated tran‐
scription factor, regulates the expression of serum amyloid P-component and C-reactive
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protein, the two critical factors implicated in innate immune responses. Like ATF6, CREBH
is an ER-membrane-bound protein. In response to ER stress, CREBH release an N-terminal
fragment and transit to nucleus to regulate the expression of target genes. Innate immune
response, in turn, regulates the expression of CREBH through inflammatory cytokines such
as IL-1β and IL-6 (60). The development of dendritic cells, the major innate immune cells, is
also regulated by ER stress response (61). High levels of mRNA splicing for XBP-1 are found
in dendritic cell, and mice deficient in XBP-1 show defective differentiation of dendritic cell.
Both conventional (CD11b+ CD11c+
) and plasmacytoid dendritic cells (B220+ CD11c+
) are decreased by >50%. Dendritic cells deficient for XBP-1 are vulnerable to ER stress-in‐
duced apoptosis (61). Moreover, the secretion of inflammatory cytokine IL-23 by dendritic
cell also involves ER stress response. CHOP, a UPR mediator, can directly bind to the IL-23
gene and regulate its transcription. ER stress combined with Toll-like receptor (TLR) ago‐
nists was found to markedly increase the mRNA of IL-23 p19 subunit and the secretion of
IL-23, while knockdown of CHOP suppressed the induction of IL-23 by ER stress and TLR
signaling (62).
The association of ER stress with innate immune response is confirmed in many disease
models. Richardson and coworkers reported that innate immune response induced by P.
aeruginosa infection causes ER stress in C. elegans, and loss-of-function mutations of XBP-1
lead to larval lethality (63). In consistent with that, polymorphisms of XBP-1 gene were
found to be associated with Crohn’s disease and ulcerative colitis in humans (64), the two
autoimmune diseases share similar properties with type 1 diabetes. Lack of XBP-1 in intesti‐
nal epithelial cells may induce Paneth cell dysfunction which further results in impaired
mucosal defense to Listeria monocytogenes and increased sensitivity to colitis (64).
In addition to IRE1/XBP-1 axis, PERK/eIF2α/ATF4 axis of UPR is also associated with innate
response. TLR signaling, the most important innate signaling pathway, can induce selective
suppression of the PERK/eIF2α/ATF-4/CHOP axis of UPR pathway (65). The activation of
TLR decreases eIF2α-induced ATF4 translation. For instance, pretreatment of LPS, an ago‐
nist for TLR4, attenuated ATF4/CHOP signaling and prevented systemic ER stress-induced
apoptosis in macrophages, renal tubule cells, and hepatocytes (65). In contrast, loss of Toll-
IL-1R-containing adaptor inducing IFN-β (TRIF), an important adapter for TLR signaling,
abrogated the protective effect of LPS on renal dysfunction and hepatosteatosis induced by
ER stress, suggesting that TLR signaling suppresses ATF4/CHOP via a TRIF-dependent
pathway (65).
4.2. ER stress and adaptive immune response
The presence of β cell specific autoantibodies is a marker for autoimmune diabetes (66).
IRE1/XBP1 axis is required for the differentiation of antibody-producing B lymphocytes.
IRE1 is necessary for the Ig gene rearrangement, production of B cell receptors, and lympho‐
poiesis. The expression multiple UPR components including BiP, GRP94, and XBP-1 is up-
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regulated during the differentiation of B cells (67). Mice with a deficiency of IRE1 in
hematopoietic cells have a defective differentiation of pro-B cells towards pre-B cells (68).
XBP-1, an IRE1 downstream molecule, is also involved in the differentiation of B cell and
antibody production by mature B cells. It was found that the engagement of B-cell receptor
induces ubiquitin-mediated degradation of BCL-6, a repressor for B-lymphocyte-induced
maturation protein 1 (69), while B-lymphocyte-induced maturation protein 1 negatively reg‐
ulates the expression of B-cell-lineage-specific activator protein (70), a repressor for XBP-1
(71). In line with these results, B lymphocytes deficient in B-lymphocyte-induced maturation
protein 1 failed to express XBP-1 in response to LPS stimulation (72). The expression of
XBP-1 is rapidly up-regulated when B cells differentiate into plasma cells. Furthermore,
XBP-1is able to initiate plasma cell differentiation when introduced into B-lineage cells.
XBP-1-deficient lymphoid chimeras have a defective B-cell-dependent immune response
due to the absence of immunoglobulin and plasma cells (30). In addition to IRE1/XBP-1 axis,
ATF6 axis may also implicated in the differentiation of B cells, as increased ATF6 cleavage is
found in differentiating B cells (67). However, PERK axis does not seem to be involved in
the B-cell differentiation and maturation (68;73).
Activation of T lymphocyte, another important adaptive immune cell, seems also involves
UPR. TCR engagement, the first T cell activation signal, induces the expression of ER chap‐
erons including BiP and GRP94. Inhibition of protein kinase C, a serine/threonine protein
kinase downstream of TCR signaling, suppresses the activation of ER stress response in‐
duced by T cell activation (74). IRE1/XBP-1 axis regulates the differentiation of effector CD8+
T cell. IRE1/XBP-1 pathway is activated in effector CD8+ T cell during acute infection. IL-2
promotes XBP-1 mRNA transcription, while TCR ligation induces the splicing of XBP-1
mRNA. The differentiation of CD8+ T cell is reduced by suppression of XBP-1 (75). Other
than IRE1/XBP-1, CHOP is also involved in the functionality of T cells. A recent report sug‐
gests GTPase of the immunity-associated protein 5 (Gimap5) mutation in BioBreeding dia‐
betes-prone rat, a model for type 1 diabetes, leads to ER stress and thus induces
spontaneous apoptosis of T cells. Inhibition of CHOP protects Gimap5-/- T cells from ER
stress-induced apoptosis (76).
4.3. ER stress regulates cytokine production
Cytokine  production  is  an  important  inflammatory  process  in  response  to  insults  of
pathogens,  mutated self-antigens or  tissue damage.  ER stress  is  interconnected with the
induction  of  inflammatory  cytokines  through  multiple  mechanisms  including  reactive
oxygen  species  (ROS),  NFκB  and  JNK  (Figure  4).  ROS  are  defined  as  highly  reactive
small molecules with unpaired electrons. They are important mediators of inflammatory
response., Oxidative stress, caused by the accumulation of ROS, was confirmed to be as‐
sociated  with  ER  stress  (77).  For  example,  the  disulphide  bond  formation  during  the
process of protein folding requires oxidizing condition (78).  Therefore,  increased protein
folding load may lead to oxidative stress. The PERK axis of UPR is able to activate anti‐
oxidant pathway by promoting ATF4 and nuclear factor-erythroid-derived 2-related fac‐
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tor  2  (NRF2)  (79;80).  Therefore,  deficiency  of  PERK  markedly  increases  ROS
accumulation in  response  to  toxic  chemicals  (79;81).  The  IRE1 axis  of  UPR can activate
NFκB, a key regulator in inflammation, by recruiting IκB kinase (82). As a result, loss of
IRE1 reduces  the  activation of  NFκB activation and production of  TNF-α (82).  In  addi‐
tion, the IRE1 axis can also activate JNK, and subsequently induce the expression of in‐
flammatory  genes  by  activating  activator  protein  1  (AP1)  (83).  ATF6,  the  third  axis  of
UPR  signaling,  can  also  activate  NFκB  pathway  and  induce  inflammatory  response.
Therefore, suppression of ATF6 reduces NFκB activation caused by BiP degradation (84).
Figure 4. UPR-mediated inflammatory signaling. UPR regulates inflammation through a variety of mechanisms in‐
volving ROS, JNK, and NFκB. PERK promotes ATF4 and NRF2, which then suppress ROS production by activating anti‐
oxidant pathway. Upon activation, IRE1/TRAF2 complex recruits IKK (IκB Kinase), leading to the phosphorylation of
IκBα and subsequent activation of NFκB. IRE1/TRAF2 can also activate JNK, followed by the activation of AP1. XBP-1
induced by IRE1 can also induce the expression of various genes implicated inflammation. Furthermore, cleaved ATF6
can promote inflammation via activating NFκB.
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ER stress regulates the expression of cytokines, while cytokines in turn may also induce ER
stress via pathways including inducible nitric oxide synthase (iNOS) and JNK. JNK pathway
is activated by IL-1β. Suppression of JNK by its inhibitor SP600125 can protectβ cells from
IL-1β-induced apoptosis (85). Inflammatory cytokines induce iNOS expression in β cells and
produce copious amount of nitric oxygen (86).Nitric oxygen is an important mediator of β-
cell death in type 1 diabetes. Excessive nitric oxygencan induce DNA damage, which leads
to β cell apoptosis through p53 pathway or necrosis through poly (ADP-ribose) polymerase
pathway (87). In addition, nitric oxygencan also deplete ER Ca2+ stores by activating Ca2+
channels or inhibiting Ca2+ pumps (88-90). Depletion of Ca2+ then leads to the activation of
CHOP and induces ER stress and apoptosis of β cells (91;92).
4.4. ER stress in the autoimmune process of type 1 diabetes
Given the involvement of ER stress in both innate and adaptive immune systems, pathways
of ER stress play a role in the autoimmune process of type 1 diabetes. For example, mice de‐
ficient in PERK, a molecule responsible for regulating UPR, are extremely susceptible to dia‐
betes. Although the exocrine and endocrine pancreas developed normally, the null mice
display a progressive loss of β mass and insulin insufficiency postnatally (93) (93). A severe
defect of β cell proliferation and differentiation was also found in PERK null mice, resulting
in low pancreatic β mass and proinsulin trafficking defects (94). Consistent with those obser‐
vations in mice, some infant-onset diabetic cases in humans are confirmed to be associated
with the mutations in PERK. For example, loss of EIF2AK3 (the gene encodes PERK) devel‐
ops Wolcott-Rallison syndrome, an autosomal recessive disorder featured by early infancy
insulin-dependency and multiple systemic manifestations including growth retardation,
hepatic/renal dysfunction, mental retardation, and cardiovascular abnormalities (86;95).
Similarly, disruption of UPR by mutating eIF2α, the downstream molecule of PERK signal‐
ing, enhances the sensitivity to ER stress-induced apoptosis and results in defective gluco‐
neogenesis. Mice carrying a homozygous Ser51Ala mutation for eIF2α show multiple
defects in pancreatic β cells including the smaller core of insulin-secreting β cells and attenu‐
ated insulin secretion (41). Altogether, defects in PERK/eIF2α signaling render β cells highly
vulnerable to ER stress in both humans and mice (87;96). In addition to PERK/eIF2α signal‐
ing, the other two pathways of ER stress, IRE1 and ATF6, are also implicated in the func‐
tionality of β cells. The activation of IRE1 signaling is involved in the insulin biosynthesis
induced by hyperglycemia. Transient exposure to high glucose enhances IRE1α phosphory‐
lation without activation of XBP-1 and BiP dissociation. IRE1α activation induced by transi‐
ent exposure to high glucose induces insulin biosynthesis by up-regulating WFS1, a
component involved in UPR and maintaining ER homeostasis (10;97). However, chronic ex‐
posure of β cells to high glucose may cause activation of IRE1 but with a different down‐
stream signaling, leading to the suppression of insulin biosynthesis (10). The activation of
ATF6 induced by ER stress also suppressed the expression of insulin by up-regulating or‐
phan nuclear receptor small heterodimer partner (98).
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5.1. The involvement of ER stress in β cell destruction
Increasing evidence suggests an important role of ER stress in autoimmune-mediated β cell
destruction (99;100). It was noted that β cell loss is the direct causing factor for insufficient
insulin secretion in type 1 diabetes patients. Pancreatic β cells have a very well-developed
ER to fulfill their biological function for secreting insulin and other glycoproteins, causing
the high sensitivity of β cells to ER stress and the subsequent UPR. Severe or long-term ER
stress would direct β cells undergoing apoptosis (99). As described earlier, all the three path‐
ways of ER stress are important in the execution of β cell function and involved in the auto‐
immune responses during the process of type 1 diabetes.
Pro-inflammatory cytokines are believed as the major mediators contributing to ER stress in
β cell mediated by autoimmune response. Autoreactive immune cells infiltrated in pancreas
produce pro-inflammatory cytokines, the primary causing factor for β cell death in type 1
diabetes(101). Autoreactive macrophages and T-lymphocytes present in the pancreatic islets
in the early stage of type 1 diabetes and secrete massive pro-inflammatory cytokines includ‐
ing IL-1β, IFN-γ and TNF-α. Pro-inflammatory cytokines have been confirmed as strong in‐
ducers of ER stress in pancreatic β cells. Insult of β cells with IL-1β and IFN-γ was reported
to induce the expression of death protein 5, a protein involved in the cytokine-induced ER
stress and β cell death (102). Suppression of death protein 5 by siRNA provides protection
for β cells against pro-inflammatory cytokine-induced ER stress (102). In addition, stimula‐
tion of β cells with IL-1β and IFN-γ can decrease the expression of sarcoendoplasmic reticu‐
lum pump Ca2+ ATPase 2b, leading to subsequent depletion of Ca2+ in the ER (103). It has
been well demonstrated that altered ER Ca2+ concentration induces the accumulation of un‐
folded proteins in ER associated with the induction of UPR and ER stress in β cells (104).
Reactive oxygen species such as nitric oxygen produced during inflammation are believed
to play a critical role in ER stress-induced β cell death. Excessive nitric oxygen production
during insulitis induces β cell apoptosis in a CHOP-dependent manner (91).
In addition to cytokine-induced ER stress, defective protein processing and trafficking are
also a direct cause of ER stress in β cell. For instance, mis-folding of insulin in β cells directly
induces chronic ER stress as evidenced by the observations in Akita mice. The mutation of
Ins2 gene in Akita mouse disrupts a disulfide bond betweenα and β chain of proinsulin,
leading to the mis-folding of the mutated insulin. This mutation therefore induces chronic
ER stress in β cells and finally causes diabetes in Akita mouse (105). The inefficiency of pro‐
tein trafficking from ER to Golgi apparatus also causes ER stress in β cells (106).
Hyperglycemia occurs only when β cells fail to compensate the increased demand for insu‐
lin. Therefore, β cells are usually “exhausted” in diabetic patients (87). The increased insulin
demandrequires the remaining functional β cellsto increase insulin synthesis to compensate
the decrease of β mass. The altered insulin synthesis causes ER stress in the β cells of pa‐
tients with type 1 diabetes. In later case, this compensation is beneficial for control of blood
glucose homeostasisin a short term.However, the long term alterations of insulin synthesis
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in the β cells also induce ER stress which in turn exacerbates β cell dysfunction and pro‐
motes disease progression. Collectively, there is convincing evidence that ER stress plays an
essential role in β cell destruction during the course of type 1 diabetes.
5.2. Mechanisms underlying ER stress-induced β cell death
The primary purpose of ER stress response is to compensate the damage caused by the dis‐
turbances of normal ER function. However, persistence of ER dysfunction would eventually
render cells undergoing apoptosis. The mechanisms underlying ER stress induced cell death
are not fully elucidated, due to the fact that multiple potential participants involved but lit‐
tle clarity on the dominant death effectors in a particular cellular context. Generally, the
process of cell death by ER stress can be illustrated in three phases: adaptation, alarm, and
apoptosis (39).
The adaptation response phase is to protect cells from damage induced by the disturban‐
ces of ER function and restore the homeostasis of ER. As described earlier, UPR signaling
involves  three  axes  of  responses:  IRE1,  PERK,  and  ATF6.  These  axes  interact  between
each other and form a feedback regulatory mechanism to control the activity of UPR. The
accumulation of unfolded proteins in ER results in the engagement of ER resident chaper‐
on BiP,  and as a consequence,  IRE1,  PERK, and ATF6 are released from BiP.  Therefore,
over-expression of BiP can prevent cell death induced by oxidative stress, Ca2+ disturban‐
ces, and hypoxia (107). Upon ER stress, the transcription of BiP is enhanced by ATF6p50,
the cleaved form of ATF6 (108). PERK is oligomerized and phosphorylated upon the re‐
lease from BiP.  Activated PERK inactivates eIF2α to reduce mRNA translation and pro‐
tein  load  on  ER.  Therefore,  PERK  deficiency  results  in  an  abnormally  elevated  protein
synthesis in response to ER stress, and renders cells highly sensitive to ER stress-induced
apoptosis  (109).  Consistently,  as  a  downstream molecule of  PERK, eIF2α is  required for
cell survival upon the insult of ER stress. A mutation at the phosphorylation site of eIF2α
(Ser51Ala) abolishes the translational suppression in response to ER stress (41). When re‐
leased  from  BiP,  IRE1  becomes  dimerized  and  activated.  Activated  IRE1  then  induces
XBP-1 by promoting the splicing of its mRNA (44). XBP-1 is responsible for the transcrip‐
tion of many adaptation genes implicated in UPR. Unlike PERK and IRE1, ATF6 translo‐
cates  into  the  Golgi  apparatus  once  released  from  BiP.  The  transmembrane  domain  of
ATF6 is cleaved in the Golgi apparatus and is then relocated into the nucleus, by which it
regulates gene expression (51).
During the alarm phase, many signal pathways are activated to alert the system. For in‐
stance, the cytoplasmic part of IRE1 can bind to TNF receptor-associated factor 2 (TRAF2),
a  key  adaptor  mediating  TNF-induced  innate  immune  response.  TRAF2  then  activates
NFκB pathway via activating IKK and activates the signaling for c-Jun N-terminal kinas‐
es (JNK) by apoptosis signal-regulating kinase 1 (Ask1). It is reported that dominant neg‐
ative TRAF2 suppresses the activation of JNK in response to ER stress (110). In addition,
TRAF2 is also a critical component for E3 ubiquitin-protein ligase complex (111). E3 ubiq‐
uitin-protein  ligase  complex  binds  to  Ubc13  and  mediates  the  noncanonical  ubiquitina‐
tion  of  substrates,  which  is  suggested  to  be  required  for  the  activation  of  JNK  (112).
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Furthermore,  IRE1 can also activate  JNK signaling by interacting with c-Jun N-terminal
inhibitory kinase (JIK) (113).
Although the purpose of UPR is to maintain the homeostasis of ER, apoptosis could occur
when the insult of ER stress exceeds the cellular regulatory capacity. Apoptosis is initiated
by the activation of several proteases including caspase-12, caspase-4, caspase-2, and cas‐
pase-9. Studies in rodents suggest that caspase-12 is activated by IRE1 and is involved in ER
stress-induced apoptosis. Mice deficient for caspase-12 are resistant to ER stress-induced
apoptosis, but remain susceptible to apoptosis induced by other stimuli (114). Caspase-12
can also be activated by TRAF2, a downstream molecule of IRE1 (113). In response to ER
stress, caspase-7 is translocated from the cytosol to the ER surface, and then activates pro‐
caspase-12 (115). Human caspase-4, the closest paralog of rodent caspase-12, can only be ac‐
tivated by ER stress-inducing reagents not by the other apoptotic reagents. Knockdown of
caspase-4 by siRNA reduces ER stress-induced apoptosis in neuroblastoma cells, suggesting
the involvement of human caspase-4 in ER stress-induced cell death (116). Similarly, cas‐
pase-2 and caspase-9 are also activated in the early phase of ER stress. Inhibition of their ac‐
tivation either by inhibitors or siRNA reduces ER stress-induced apoptosis (117). Other than
caspase proteins, Ask1 kinase and CHOP are also critical mediators for ER stress-induced
cell death. IRE1/TRAF2 complex recruits Ask1 and activates subsequent JNK signaling. The
activation of JNK then induces apoptosis by inhibiting anti-apoptotic protein BCL-2 (118)
and inducing pro-apoptotic protein Bim (119;120). Deficiency of Ask1 suppresses ER stress-
induced JNK activation and protects cells against ER stress-induced apoptosis (121). CHOP,
a transcription factor belonging to basic leucine zipper transcription factor family, can be ac‐
tivated by many inducers of UPR including ATF4, ATF6, and XBP-1. Upon activation,
CHOP induces cells undergoing apoptosis through suppressing anti-apoptotic protein
BCL-2 (122-124).
6. Conclusions and future directions
Although exogenous insulin therapy partly compensates the function of β cells, it cannot
regulate  blood  glucose  as  accurately  as  the  action  of  endogenous  insulin.  As  a  result,
long-term improperly control of blood glucose homeostasis predisposes patients with type
1  diabetes  to  the  development  of  diverse  complications  such  as  diabetic  retinopathy
(125-127),  nephropathy (128;129),  neuropathy (130-132),  foot ulcers (133-135),  and cardio‐
vascular diseases (136-138). Due to the long-term health consequences of diabetes, impact
of insulin dependence on life quality,  and increasing appearance in both young and old
populations, understanding the pathophysiology of diabetes and finding a better way to
treat diabetes has become a high priority.  Although the underlying mechanisms leading
to type 1 diabetes have yet to be fully addressed, accumulating evidence suggests that ER
stress plays a critical role in autoimmune-mediated β cell destruction during the course of
type  1  diabetes.  ER  stress  in  β  cells  can  be  triggered  by  either  autoimmune  responses
against  β-cell  self-antigens or  the increase of  compensated insulin synthesis.  During the
course of type 1 diabetes, autoreactive immune cells secrete copious amount of inflamma‐
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tory cytokines,  leading to excessive production of nitric  oxygenand β cell  destruction in
an  ER  stress-dependent  pathway.  ER  stress  also  regulates  the  functionality  of  immune
cells  with  implications  in  autoimmune  progression.  The  inadequate  insulin  secretion  in
patients with type 1 diabetes renders the residual β cells for compensated insulin secre‐
tion  to  maintain  blood glucose  homeostasis.  This  increase  in  insulin  biosynthesis  could
overwhelm the folding capacity of ER, and exacerbate β cell dysfunction by inducing ER
stress in β cells.
Although ER stress is a critical factor involved in the pathogenesis of type 1 diabetes, it
should be kept in mind that the mechanisms underlying autoimmune-mediated β cell de‐
struction in type 1 diabetes are complex, and ER stress is unlikely the exclusive mechanism
implicated in disease process. Despite recent significant progress in this area, there are still
many questions yet to be addressed. Are there additional factors inducing ER stress in β
cells during type 1 diabetes development? Can ER stress be served as a biomarker for β cell
destruction and autoimmune progression in the clinic setting? Does blockade of ER stress in
immune cells attenuate autoimmune progression and protect β cells? Future studies aimed
to dissect these questions would provide a deep insight for type 1 diabetes pathogenesis and
would have great potential for developing novel therapeutic strategies against this devastat‐
ing disorder.
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